Human immunodeficiency virus (HIV)-specific IgA and HIV neutralizing activity in the serum of exposed seronegative partners of HIV-seropositive persons

J Infect Dis. 1999 Sep;180(3):871-5. doi: 10.1086/314934.

Abstract

The presence and activity of human immunodeficiency virus (HIV)-specific antibodies were analyzed in the sera of 15 sexually exposed seronegative persons who had systemic HIV-specific cell-mediated immunity and IgA-mediated mucosal immunity and in their HIV-infected partners. The HIV-positive subjects had HIV-specific serum IgG and IgA; the seronegative persons had HIV-specific serum IgA in the absence of IgG. Testing of the seronegative persons 1 year after the interruption of at-risk sex showed that no IgG seroconversion had occurred and that HIV-specific IgA serum concentrations had declined. Serum from the HIV-exposed seronegative persons was analyzed for the ability to neutralize primary HIV-1 isolates. Neutralizing activity was detected in 5 of 15 sera and in 2 cases was retained by serum-purified IgA. Thus, the immunologic picture for resistance to HIV infection should include HIV-specific cell-mediated immunity as well as HIV-specific IgA-mediated mucosal and systemic immunity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Female
  • HIV Antibodies / blood*
  • HIV Seronegativity / immunology*
  • HIV Seropositivity / immunology*
  • HIV Seropositivity / transmission
  • HIV-1 / immunology*
  • Humans
  • Immunoglobulin A / blood*
  • Immunoglobulin G / blood
  • Male
  • Neutralization Tests
  • Risk Factors
  • Risk-Taking
  • Sexual Behavior*

Substances

  • HIV Antibodies
  • Immunoglobulin A
  • Immunoglobulin G